Trial intelligence / Profile preview

Anterior vs Posterior Hydrodilatation for Adhesive Capsulitis

NCT05194852Completed

Sponsor
Tanta University
Start
Jan 2018
Primary completion
Jun 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, open-label trial of ropivacaine in adhesive capsulitis of shoulder (AC), sponsored by Tanta University. Primary endpoints: Visual Analogue Scale at 3 months and Shoulder Pain and Disability Index at 3 months. Started Jan 2018; status: completed.

02

Drugs

ropivacaine
03

Conditions

adhesive capsulitis of shoulder (AC)

Beyond the preview

Go deeper on NCT05194852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05194852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call